Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use. (Q42507739)

1 November 2017

Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use. (English)

1 reference

1 November 2017

1 reference

Lionel Stephan

1

1 reference

1 November 2017

Christophe Pichavant

2

1 reference

1 November 2017

Manaf Bouchentouf

3

1 reference

1 November 2017

Philippe Mills

4

1 reference

1 November 2017

Geoffrey Camirand

5

1 reference

1 November 2017

Saloua Tagmouti

6

1 reference

1 November 2017

David Rothstein

7

1 reference

1 November 2017

Jacques P Tremblay

8

1 reference

1 November 2017

1 January 2006

1 reference

1 November 2017

1 reference

1 November 2017

15

1 reference

1 November 2017

8-9

1 reference

1 November 2017

835-846

1 reference

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

1 November 2017

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Normal myoblast implantation in MDX mice prevents muscle damage by exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Treosulfan as an effective second-line therapy in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Somatic reversion/suppression of the mouse mdx phenotype in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Acute left ventricular failure following melphalan and fludarabine conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Mixed chimerism as an approach for the induction of transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Lymphocyte infiltration following allo-and xenomyoblast transplantation in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

Transplantation of Human Myoblasts in SCID Mice as a Potential Muscular Model for Myotonic Dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F000000006783981521

10.3727/000000006783981521

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference